GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » Gross Margin %

Oxford Nanopore Technologies (LSE:ONT) Gross Margin % : 48.93% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Oxford Nanopore Technologies's Gross Profit for the six months ended in Dec. 2023 was £40.9 Mil. Oxford Nanopore Technologies's Revenue for the six months ended in Dec. 2023 was £83.7 Mil. Therefore, Oxford Nanopore Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 48.93%.


The historical rank and industry rank for Oxford Nanopore Technologies's Gross Margin % or its related term are showing as below:

LSE:ONT' s Gross Margin % Range Over the Past 10 Years
Min: 41.17   Med: 51.29   Max: 62.34
Current: 53.33


During the past 6 years, the highest Gross Margin % of Oxford Nanopore Technologies was 62.34%. The lowest was 41.17%. And the median was 51.29%.

LSE:ONT's Gross Margin % is ranked worse than
55.87% of 741 companies
in the Biotechnology industry
Industry Median: 59.43 vs LSE:ONT: 53.33

Oxford Nanopore Technologies had a gross margin of 48.93% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Oxford Nanopore Technologies was 4.10% per year.


Oxford Nanopore Technologies Gross Margin % Historical Data

The historical data trend for Oxford Nanopore Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Gross Margin % Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 49.21 41.17 54.76 62.34 53.33

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.54 63.71 60.14 57.61 48.93

Competitive Comparison of Oxford Nanopore Technologies's Gross Margin %

For the Biotechnology subindustry, Oxford Nanopore Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Gross Margin % falls into.



Oxford Nanopore Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Oxford Nanopore Technologies's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=90.5 / 169.668
=(Revenue - Cost of Goods Sold) / Revenue
=(169.668 - 79.187) / 169.668
=53.33 %

Oxford Nanopore Technologies's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=40.9 / 83.666
=(Revenue - Cost of Goods Sold) / Revenue
=(83.666 - 42.732) / 83.666
=48.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Oxford Nanopore Technologies  (LSE:ONT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Oxford Nanopore Technologies had a gross margin of 48.93% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Oxford Nanopore Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (LSE:ONT) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines